NCT05451186

Brief Summary

This study was planned to investigate the effects of eye patch and headphones on sleep quality, anxiety, fear and vital signs in coronary intensive care unit patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 20, 2022

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

July 6, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 11, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2022

Completed
Last Updated

February 13, 2023

Status Verified

February 1, 2023

Enrollment Period

5 months

First QC Date

July 6, 2022

Last Update Submit

February 10, 2023

Conditions

Keywords

Intensive Care UnitHeadphonesSleep bandsSleep

Outcome Measures

Primary Outcomes (4)

  • Visual Analog Scale (Fear)

    Patients are asked to show the severity of their fear on a 10 cm long vertical or horizontal line. In addition, there were forms which were numbered from 1-10 or from 1-100. The number 0 is found at the beginning of the line, and the number 10 is located at the end of the line. A value of 0 shows that there is no pain, and the value 10 expresses unendurable pain. GAS is a common scale in the assessment of pain level. A patient is asked to mark the perceived pain on this line, and the marked point is measured in cm.

    the first day after receiving randomisation

  • Visual Analog Scale (Anxiety)

    Patients are asked to show the severity of their anxiety on a 10 cm long vertical or horizontal line. In addition, there were forms which were numbered from 1-10 or from 1-100. The number 0 is found at the beginning of the line, and the number 10 is located at the end of the line. A value of 0 shows that there is no pain, and the value 10 expresses unendurable pain. GAS is a common scale in the assessment of pain level. A patient is asked to mark the perceived pain on this line, and the marked point is measured in cm.

    the first day after receiving randomisation

  • Vital Signs Follow-up Form

    This form was created by the researcher in order to record the systolic-diastolic blood pressure, and heart rate (pulse), values of the patient who was applied an eye patch or earphone at night.

    the first day after receiving randomisation

  • The Richards-Campbell Sleep Questionnaire

    This brief five-item questionnaire was used to evaluate perceived sleep depth, sleep latency (time to fall asleep), number of awakenings, efficiency (percentage of time awake), and sleep quality. It also includes a sixth item evaluating perceived night-time noise. Each item is evaluated on a scale of 0-100 with a visual analogue scale technique. A score of 0-25 indicates very poor quality sleep, whereas a score of 76-100 indicates very good sleep quality.

    the first day after receiving randomisation

Secondary Outcomes (4)

  • Visual Analog Scale (Fear)

    4. days

  • Visual Analog Scale (Anxiety)

    4. days

  • Vital Signs Follow-up Form

    4. days

  • The Richards-Campbell Sleep Questionnaire

    4. days

Study Arms (2)

Eye patch and headphones

EXPERIMENTAL

Eye patch and headphones

Other: Eye patch and headphones

Control group

NO INTERVENTION

Routine maintenance will be applied

Interventions

Patients in the experimental group will be asked to use an eye mask and earplugs from 22:30 to 6:30 in the morning on the 1st, 2nd and 3rd nights.

Eye patch and headphones

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being 18 years or older,
  • New York Heart Association (NYHA) functional class II and III,
  • Not having received any general anaesthesia for the previous 24 hours,
  • Not having received any sedative medications or opioids for the past 24 hours,
  • Not having a verbal communication disability (hearing and speaking),
  • Absence of pain,
  • Not having a previously diagnosed sleep disorder,
  • Not having psychiatric problems,
  • Not having a cognitive problem,
  • Being healthy enough to put on and take off earplugs independently, in addition to wearing an eye mask and removing it when necessary, and continuing to be hospitalized for at least three days.

You may not qualify if:

  • Diagnosed with delirium (Intensive care delirium screening checklist \>=5),
  • Unconscious (Glasgow coma scale\<13),
  • Presence of additional chronic diseases,
  • Having consumed coffee, alcohol and hypnotic drugs at least 12 hours before the study,
  • Patients whose condition suddenly worsened,
  • Those who cannot use earplugs and eye masks effectively at night,
  • Those who voluntarily withdrew from the study and were transferred from the intensive care unit.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Sabahattin Zaim University, Faculty of Health Sciences

Istanbul, 34340, Turkey (Türkiye)

Location

Related Publications (1)

  • Kasapoglu ES, Enc N. Role of multicomponent non-pharmacological nursing interventions on delirium prevention: A randomized controlled study. Geriatr Nurs. 2022 Mar-Apr;44:207-214. doi: 10.1016/j.gerinurse.2022.02.015. Epub 2022 Feb 26.

Study Officials

  • Zülfünaz Özer

    Istanbul Sabahattin Zaim University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Experimental group and control group
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: This research is a single-blind study with a pretest-posttest randomized control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Investigator

Study Record Dates

First Submitted

July 6, 2022

First Posted

July 11, 2022

Study Start

June 20, 2022

Primary Completion

November 15, 2022

Study Completion

November 15, 2022

Last Updated

February 13, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations